Inhibiting casein kinase 2 sensitizes acute lymphoblastic leukemia cells to venetoclax via MCL1 degradation
Journal:
Blood Adv
Year of publication:
2021
Citation:
2021 Dec 28;5(24):5501-5506.
doi:
10.1182/bloodadvances.2021004513
PubMed:
PubMed (PMID: 34610112)
Impact factor:
–
Abstract:
–